T1	PROC 47 75	Estudio abierto de extensión
T2	PROC 81 127	evaluar la seguridad, tolerabilidad y eficacia
T3	PROC 146 167	tratamiento combinado
T4	CHEM 171 180	pozelimab
T5	CHEM 183 193	cemdisirán
T6	LIVB 197 206	pacientes
#1	AnnotatorNotes T6	C0030705; Patients; Patient or Disabled Group
T7	DISO 211 246	hemoglobinuria paroxística nocturna
#2	AnnotatorNotes T7	C0024790; Paroxysmal nocturnal hemoglobinuria; Disease or Syndrome
T8	DISO 261 296	hemoglobinuria paroxística nocturna
#3	AnnotatorNotes T8	C0024790; Paroxysmal nocturnal hemoglobinuria; Disease or Syndrome
T9	DISO 298 301	HPN
#4	AnnotatorNotes T9	C0024790; Paroxysmal nocturnal hemoglobinuria; Disease or Syndrome
T10	LIVB 332 341	Pacientes
#5	AnnotatorNotes T10	C0030705; Patients; Patient or Disabled Group
T11	DISO 346 349	HPN
#6	AnnotatorNotes T11	C0024790; Paroxysmal nocturnal hemoglobinuria; Disease or Syndrome
T12	Neg_cue 370 373	sin
T13	PROC 374 397	interrupción permanente
T14	Negated 374 386	interrupción
T15	Negated 387 397	permanente
T16	PROC 402 413	tratamiento
#7	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	PROC 610 619	protocolo
#8	AnnotatorNotes T17	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T18	PROC 682 691	protocolo
#9	AnnotatorNotes T18	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T19	LIVB 737 749	investigador
#10	AnnotatorNotes T19	C0035173; Research Personnel; Professional or Occupational Group
T20	Spec_cue 789 799	afectarían
T21	LIVB 847 855	paciente
#11	AnnotatorNotes T21	C0030705; Patients; Patient or Disabled Group
T22	PROC 902 932	administración del medicamento
T23	LIVB 947 955	paciente
#12	AnnotatorNotes T23	C0030705; Patients; Patient or Disabled Group
T24	DISO 971 981	enfermedad
#13	AnnotatorNotes T24	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T25	DISO 1011 1021	enfermedad
#14	AnnotatorNotes T25	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T26	LIVB 1052 1064	investigador
#15	AnnotatorNotes T26	C0035173; Research Personnel; Professional or Occupational Group
T27	LIVB 1078 1086	paciente
#16	AnnotatorNotes T27	C0030705; Patients; Patient or Disabled Group
T28	Neg_cue 1087 1089	no
T29	Negated 1094 1118	adecuado para participar
T30	Spec_cue 1121 1126	pueda
T31	Speculated 1127 1137	interferir
T32	LIVB 1159 1167	paciente
#17	AnnotatorNotes T32	C0030705; Patients; Patient or Disabled Group
T33	PROC 1264 1273	protocolo
#18	AnnotatorNotes T33	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T34	Speculated 833 855	seguridad del paciente
T35	PROC 449 467	estudios de origen
T36	Speculated 804 825	objetivos del estudio
T37	CONC 374 386	interrupción
T38	Quantifier_or_Qualifier 387 397	permanente
T39	CONC 515 536	periodo de transición
T40	Quantifier_or_Qualifier 565 570	otros
T41	CONC 571 593	criterios de inclusión
T42	Observation 650 691	Desviaciones significativas del protocolo
T43	Observation 789 799	afectarían
T44	Observation 870 895	incumplimiento repetitivo
T45	Observation 902 916	administración
T46	Quantifier_or_Qualifier 982 987	nueva
T47	Observation 990 1003	empeoramiento
T48	Observation 1094 1118	adecuado para participar
T49	CONC 1127 1137	interferir
T50	Observation 1173 1206	participar o finalizar el estudio
T51	Quantifier_or_Qualifier 1219 1224	otros
T52	CONC 1225 1247	criterios de inclusión
T53	Patient 197 206	pacientes
T54	Patient 332 341	Pacientes
T55	Other 737 749	investigador
T56	Patient 847 855	paciente
T57	Patient 947 955	paciente
T58	History_of 1011 1021	enfermedad
T59	Other 1052 1064	investigador
T60	Patient 1078 1086	paciente
T61	Patient 1159 1167	paciente
